Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma Sizes Up The Affordable Care Act: Buyer’s Remorse Or Winner’s Curse?

Jul 23 2013

Related Content

Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition

Oct 01 2011

Pharma Industry Likely To Take Wait-And-See Approach To GSK U.S. Sales Incentive Changes

Aug 02 2010

On The Wings Of <em>Lantus</em>: Sanofi Sees Clearer Skies Ahead In Diabetes

Apr 15 2013

New Insurance Marketplaces Won’t ‘Move The Needle’ Near-Term For Pharma Economics – An Interview With Booz & Co.

Mar 18 2013

Opening A Door To Biosimilars In The US

Sep 01 2010

Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts

Jul 01 2010

Price Controls in Action: Understanding the Rise of the 340B Program

Apr 01 2011

GSK’s New Commercial Model Will “Stay The Course” Regardless Of ACA’s Future

Jun 04 2012

Pharma Plus: Merck’s Global Health Innovation Fund

Sep 19 2011

Takeda Treads Carefully With DPP-4 Late-Arrival <em>Nesina</em>, Plans Summer Launch

Feb 04 2013

Related Companies

GSK plc

Takeda Pharmaceutical Co. Ltd.

Sanofi

Takeda Pharmaceutical Co. Ltd.

AgaMatrix

Regeneron Pharmaceuticals, Inc.

Horizon Therapeutics plc

Cubist Pharmaceuticals, Inc.

Merck & Co., Inc.

Additional Topics

United States Business Strategies Legislation Leadership Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window